Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
893642-52-9
790263-61-5
790270-87-0 | 1-(3-acetylbenzenesulfonyl)piperidine-4-carboxylic acid | AA019JOV | MFCD06357843
1049712-52-8 | 5-(aminomethyl)-N-methylthiophene-2-sulfonamide hydrochloride | AA019K0X | MFCD08457596
923191-32-6 | 2-[(2,5-dioxoimidazolidin-1-yl)methyl]benzonitrile | AA019K6A | MFCD08691174
99229-16-0 | 2-[(2,2,2-trifluoroethyl)sulfanyl]aniline | AA019KCF | MFCD08729259
956728-61-3 | 2-[4-(1H-pyrazol-1-ylmethyl)phenyl]benzonitrile | AA019KH3 | MFCD09040550
334974-43-5 | N-(1-Benzylpiperidin-4-yl)-2-chloropropanamide | AA019KMY | MFCD00832303
1087792-04-8 | Methyl 2-(4,5-dichloro-6-oxopyridazin-1(6h)-yl)benzoate | AA019KT0 | MFCD11099390
70826-93-6 | 1-(4-Aminophenyl)-3-(propan-2-yl)urea | AA019KX8 | MFCD11167417
200505-18-6 | 2-(Quinolin-8-yloxy)acetic acid hydrochloride | AA019L3P | MFCD01202563
891038-92-9 | 3-Methyl-4-(1h-tetrazol-1-yl)aniline | AA019L8L | MFCD09048464
87073-90-3
401571-11-7
1261395-28-1
932530-47-7
1008695-64-4
Journal: Bioorganic & medicinal chemistry letters20101101